Literature DB >> 30346617

Gross tumor volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.

Hidenori Suzuki1, Kana Kimura2, Takeshi Kodaira3, Hiroyuki Tachibana3, Natsuo Tomita3, Yutaro Koide3, Hiroshi Tanaka3, Daisuke Nishikawa1, Yusuke Koide1, Shintaro Beppu1, Nobuhiro Hanai1.   

Abstract

OBJECTIVE: This study investigated whether gross tumor volume of the primary tumor before treatment was a predictor for local recurrence in patients with resectable sinonasal tract squamous cell carcinoma who were treated by chemoradiotherapy.
METHODS: A total of 24 patients were enrolled. Pretreatment gross tumor volume of primary tumor was assessed by palpitation, perception and imaging. The cut-off value of the gross tumor volume for local recurrence was determined by receiver-operating curve analysis. A log-rank test and Cox's proportional hazards model were used for univariate and multivariate analyses with adjustment for the clinical T category (cT1-T4a/cT4b), respectively.
RESULTS: In the univariate analysis, patients with the gross tumor volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.0023) and disease-free survival (P = 0.0064) than those with gross tumor volume <83.7 ml. In the multivariate analysis, gross tumor volume ≥83.7 ml were significantly associated with shorter local recurrence-free rate (P = 0.041).
CONCLUSIONS: Pretreatment gross tumor volume of primary tumor ≥83.7 ml was significantly associated with local recurrence-free rate in resectable sinonasal tract squamous cell carcinoma.

Entities:  

Mesh:

Year:  2018        PMID: 30346617     DOI: 10.1093/jjco/hyy147

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  1 in total

1.  Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Takeshi Kodaira; Masami Nishio; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Nobuhiro Hanai
Journal:  Diagnostics (Basel)       Date:  2022-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.